
Article
Peptides for Muscle Growth: Where the Human Evidence Ends
More lean mass sounds like stronger muscles. Tesamorelin research shows why those two claims need separate evidence—and why the people included in a trial matter.
Read article
Article
More lean mass sounds like stronger muscles. Tesamorelin research shows why those two claims need separate evidence—and why the people included in a trial matter.
Read article
Article
Two serums can share an ingredient without sharing the evidence. A small copper-peptide study shows why the carrier, comparison and people studied matter.
Read article
Article
A smaller number on the scale, less liver fat and less fat around internal organs answer different questions. Four compounds reveal why the measurement matters.
Read article
Article
When concentration feels less reliable, it is tempting to look for a clear winner. The Semax literature shows why brain scans and better task performance are not the same evidence.
Read article
Article
A short hormone-response experiment and a surgical trial tell a narrower story than many people expect when they look up ipamorelin.
Read article
Article
Weight-loss percentages can look decisive until you notice the trials measured different people, doses, timelines, and outcomes. Here is what the comparison can honestly say.
Read article
Article
A laboratory signal in older muscle is not the same thing as more energy in daily life. Here is what controlled SS-31 trials measured—and what they did not.
Read article
Article
Kisspeptin has a real but narrow human research record, centred on reproductive hormone signalling and specialised fertility studies—not general hormone health or menopause.
Read article